Viz.ai
Vizion Expert Series
Vizion is a new space for expanding your knowledge on the future of AI in healthcare. We’re excited to launch a new series of interviews highlighting the voices shaping the healthcare, pharma, and medical device industries—jump into the first episode of the Vizion Expert Series.
Glöm inte att besöka poddens webbplats och stötta skaparen: vizai.podbean.com
Var kan du lyssna?
Poddar i appen Replaio Radio Kommer snartPoddar kommer snart till appen. Installera nu och bli först med att uppleva ett helt nytt sätt att lyssna på poddar
Avsnitt
Vizion Expert Series | Closing the Cardiology Care Gap with AI 24.06.2026 27:06
In this episode of the Vizion Expert Series, host Tim Showalter, MD, Chief Medical Officer at Viz.ai, sits down with cardiologist Dr. Ugo Egolum of Georgia Heart Institute to explore how AI is closing the diagnosis gap in cardiology. They discuss why cardiac amyloidosis is far more common than once believed, how AI-enabled ECG and echo screening can surface at-risk patients before they become symp...
Vizion Expert Series | AI in Prostate Cancer Care 25.02.2026 41:55
In this episode, hosts Rebecca Maniago, PharmD, BCOP, Senior Director, Oncology Care Pathway at Viz.ai, and Tim Showalter, MD, MPH, Chief Clinical Officer at Viz.ai, are joined by Adam P. Dicker, MD, PhD, FASTRO, FASCO, EVP & Chair, Radiation Oncology at Thomas Jefferson University, and Paul M. Yonover, MD, FACS, Chief Data Officer at Uropartners, Specialty Alliance.
Vizion Expert Series | Clinical AI’s Tipping Point 23.09.2025 27:50
In this episode of Vizion Expert Series, Dr. Gaurav Singal — physician, data scientist, Harvard faculty member, and former Chief Data Officer at Foundation Medicine — shares why AI is finally being embraced by clinicians, and how the current wave of healthcare AI differs from past technological efforts. Dr. Singal draws from deep experience in data science, health tech, and business strategy to ex...
Liknande poddar
Replaio är ingen poddutgivare; programnamn, omslag och ljud tillhör sina upphovspersoner och distribueras via offentliga RSS-flöden